Compare INFU & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | RPID |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.8M | 204.3M |
| IPO Year | 2005 | 2021 |
| Metric | INFU | RPID |
|---|---|---|
| Price | $10.65 | $2.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $15.00 | $8.00 |
| AVG Volume (30 Days) | 80.1K | ★ 202.2K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | 2.78 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $143,436,000.00 | $33,587,000.00 |
| Revenue This Year | $3.20 | $19.12 |
| Revenue Next Year | $7.31 | $18.42 |
| P/E Ratio | $33.32 | ★ N/A |
| Revenue Growth | 6.36 | ★ 19.74 |
| 52 Week Low | $4.66 | $2.01 |
| 52 Week High | $11.04 | $4.94 |
| Indicator | INFU | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 63.82 | 45.97 |
| Support Level | $8.52 | $2.04 |
| Resistance Level | $10.84 | $2.46 |
| Average True Range (ATR) | 0.39 | 0.14 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 78.32 | 69.38 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.